ID
16329
Description
Assessment of Endometrial Changes in Postmenopausal Women With Breast Cancer in Adjuvant Treatment With Anastrozole; ODM derived from: https://clinicaltrials.gov/show/NCT00623519
Link
https://clinicaltrials.gov/show/NCT00623519
Keywords
Versions (1)
- 7/11/16 7/11/16 -
Uploaded on
July 11, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT00623519
Eligibility Breast Cancer NCT00623519
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
metastatic disease
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1282506
- UMLS CUI [1,2]
- C0027627
Description
patients unsuitable to receive the medication according the anastrozole label
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0290883
- UMLS CUI [1,2]
- C3839996
Description
informed consent
Data type
boolean
Alias
- UMLS CUI [1]
- C0021430
Similar models
Eligibility Breast Cancer NCT00623519
- StudyEvent: Eligibility
C0678222 (UMLS CUI [1,2])
C1514888 (UMLS CUI [1,3])
C0279025 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2])
C0949878 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,2])
C3839996 (UMLS CUI [1,2])